Pfizer CEO Complains to Investors About Lower Drug Prices Under Inflation Reduction Act

Chief executive Albert Bourla said Manchin and Schumer were “wrong” to “single out” the pharmaceutical industry in seeking cost savings for the government. The post Pfizer CEO Complains to Investors About Lower Drug Prices Under Inflation Reduction Act appeared first on The Intercept.

The, Doctor